Cytokine release syndrome in adults with acute leukemia after allo-HCT with posttransplant cyclophosphamide prophylaxis.

N. Volkov I. Moiseev A. Botina D. Zhogolev A. Beynarovich S. Ziganshina Aleksandr A. Siniaev Y. Vlasova T. Rudakova Y. Rogacheva K. Afanaseva Marina Popova M. Vladovskaya Sergey Bondarenko Alexander D. Kulagin

Sep 2026 · International journal of hematology · 0 citations · 24 references

Medicine

TL;DR

HLA mismatch and peripheral blood grafts are associated with CRS, which may precede subsequent aGVHD, and Ruxolitinib administration for extensive cutaneous involvement was associated with resolution of skin manifestations.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Oct 2026

Hematopoietic Cell Transplantation Outcomes in the Era of Post-Transplant Cyclophosphamide: Comprehensive Donor Analysis.

It is suggested that PTCy narrows outcome differences across donor types, shifting donor selection from rigid hierarchies and supporting timely HCT using the best available donor.

Y. Aljawai, Masumi Ueda Oshima, Varuna Astha et al. · Blood Advances · 0 citations

Review Open access Sep 2026

Secondary failure of platelet recovery after allogeneic hematopoietic stem cell transplantation in pediatric acquired aplastic anemia: Incidence, risk factors, and clinical outcomes

Secondary failure of platelet recovery (SFPR) poses a significant risk for life-threatening complications following hematopoietic stem cell transplantation (HSCT). However, the incidence, clinical outcomes, and risk factors associated with SFPR in the context of allogeneic HSCT (allo-HSCT) for pediatric patients with a...

Yue Shang, Yuan-Yuan Ren, Li-Peng Liu et al. · Clinical Hematology Internat... · 0 citations

Open access Sep 2026

Vorinostat for graft-versus-host disease prevention in pediatric and young adult patients with hematologic malignancies.

BACKGROUND This prospective, single-arm, multicenter phase 1/2 trial evaluated vorinostat added to standard graft-versus-host disease (GVHD) prophylaxis in pediatric, adolescent, and young adult (AYA) patients undergoing allogeneic hematopoietic cell transplantation (HCT) from HLA-matched related, HLA-matched unrelated...

Nicolas Parnell, Xiao Cao, J. H. Beumer et al. · JCI Insight · 0 citations

Sep 2026

Cytokine release syndrome in adults with acute leukemia after allo-HCT with posttransplant cyclophosphamide prophylaxis.

Similar papers

Hematopoietic Cell Transplantation Outcomes in the Era of Post-Transplant Cyclophosphamide: Comprehensive Donor Analysis.

Secondary failure of platelet recovery after allogeneic hematopoietic stem cell transplantation in pediatric acquired aplastic anemia: Incidence, risk factors, and clinical outcomes

Vorinostat for graft-versus-host disease prevention in pediatric and young adult patients with hematologic malignancies.

Allogeneic transplantation outcomes in chronic myeloid leukemia in the era of tyrosine kinase inhibitors.

Immune Reconstitution in Pediatric Patients Post Autologous Stem Cell Transplantation.

Allogeneic hematopoietic stem cell transplantation from matched related donors for acute myeloid leukemia